Debates & Insight Sponsored Available on demand: Measuring the cost of the right interve... Available on Demand: Measuring the cost of the right interventions in diabetes.
Views & Analysis Cancer central to ‘Question Time’-style debate Topics, ranging from the seven-days- a-week NHS to Brexit, were on the oncology panel's agenda.
News British pharma, biotech reiterate ‘Remain’ support On the eve of the hugely important referendum, the result is too close to call.
News Janssen's RA candidate among hot topics at EULAR But attendees warned to expect "oceanic" weather.
Pharma Market Access Accelerated Access Review: no panacea for UK pharma What can the AAR do for the UK pharma industry, the health service and patients?
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
